LIFECORE BIOMEDICAL, INC. Payment for Debt Extinguishment or Debt Prepayment Cost
LIFECORE BIOMEDICAL, INC. (LFCR) reported Payment for Debt Extinguishment or Debt Prepayment Cost of $0 for the 12-month period ending 2019-05-26, per its 10-K filed 2019-08-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtExtinguishmentCosts · last filed 2019-08-01
- LIFECORE BIOMEDICAL, INC. payment for debt extinguishment or debt prepayment cost for the quarter ending 2017-05-28 was $0.00.
- LIFECORE BIOMEDICAL, INC. payment for debt extinguishment or debt prepayment cost for the quarter ending 2017-02-26 was $0.00.
- LIFECORE BIOMEDICAL, INC. payment for debt extinguishment or debt prepayment cost for the quarter ending 2016-11-27 was $233.00K.
- LIFECORE BIOMEDICAL, INC. payment for debt extinguishment or debt prepayment cost for fiscal 2019 was $0.00.
- LIFECORE BIOMEDICAL, INC. payment for debt extinguishment or debt prepayment cost for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- LIFECORE BIOMEDICAL, INC. payment for debt extinguishment or debt prepayment cost for fiscal 2017 was $233.00K.
| Period end | Payment for Debt Extinguishment or Debt Prepayment Cost | Payment for Debt Extinguishment or Debt Prepayment Cost 3 month | Payment for Debt Extinguishment or Debt Prepayment Cost 6 month | Payment for Debt Extinguishment or Debt Prepayment Cost 9 month | Payment for Debt Extinguishment or Debt Prepayment Cost 12 month |
|---|---|---|---|---|---|
| 2019-05-26 | $0.00 10-K · filed 2019-08-01 | ||||
| 2018-05-27 | $0.00 10-K · filed 2019-08-01 | ||||
| 2017-05-28 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-01 | $0.00 derived: sum of 2 quarters · filed 2019-08-01 | $233.00K derived: sum of 3 quarters · filed 2019-08-01 | $233.00K 10-K · filed 2019-08-01 | |
| 2017-02-26 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-04-05 | $233.00K derived: sum of 2 quarters · filed 2018-04-05 | $233.00K 10-Q · filed 2018-04-05 | ||
| 2016-11-27 | $233.00K 10-Q · filed 2017-04-07 | $233.00K 10-Q · filed 2018-01-05 | |||
| 2016-09-23 | $233.00K 10-K · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |